These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38150190)

  • 1. Usefulness of the DN4, S-LANSS, and painDETECT screening questionnaires to detect the neuropathic pain components in people with acute whiplash-associated disorders: a cross-sectional study.
    Ríos-León M; Taylor J; Segura-Fragoso A; Barriga-Martín A
    Pain Med; 2024 May; 25(5):344-351. PubMed ID: 38150190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of four commonly used neuropathic pain screening questionnaires in patients with chronic low back pain: a cross-sectional study.
    Gudala K; Ghai B; Bansal D
    Korean J Pain; 2017 Jan; 30(1):51-58. PubMed ID: 28119771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening tools for neuropathic pain: can they be of use in individuals with spinal cord injury?
    Hallström H; Norrbrink C
    Pain; 2011 Apr; 152(4):772-779. PubMed ID: 21272997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.
    Hamdan A; Luna JD; Del Pozo E; Gálvez R
    Eur J Pain; 2014 Jan; 18(1):101-9. PubMed ID: 23776139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of painDETECT and S-LANSS in identifying the neuropathic component of mixed pain among patients with tumor-related cancer pain.
    Higashibata T; Tagami K; Miura T; Okizaki A; Watanabe YS; Matsumoto Y; Morita T; Kinoshita H
    Support Care Cancer; 2020 Jan; 28(1):279-285. PubMed ID: 31041583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agreement Between the Douleur Neuropathique in 4 Questions and Leeds Assessment of Neuropathic Symptoms and Signs Questionnaires to Classify Neuropathic Pain Among Patients with Leprosy.
    Santana JC; Santos VS; Gurgel RQ; Santana JC; Reis FP; Cuevas LE; Feitosa VL
    Am J Trop Med Hyg; 2016 Oct; 95(4):756-759. PubMed ID: 27458041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for neuropathic characteristics in failed back surgery syndromes: challenges for guiding treatment.
    Markman JD; Kress BT; Frazer M; Hanson R; Kogan V; Huang JH
    Pain Med; 2015 Mar; 16(3):520-30. PubMed ID: 25530081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.
    Walsh J; Rabey MI; Hall TM
    J Manipulative Physiol Ther; 2012; 35(3):196-202. PubMed ID: 22397741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathic pain screening questionnaires have limited measurement properties. A systematic review.
    Mathieson S; Maher CG; Terwee CB; Folly de Campos T; Lin CW
    J Clin Epidemiol; 2015 Aug; 68(8):957-66. PubMed ID: 25895961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic neuropathic pain in the hospital setting: use of screening tools.
    Sadler A; Wilson J; Colvin L
    Clin J Pain; 2013 Jun; 29(6):507-11. PubMed ID: 23247003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which scale is more useful to detect diabetic neuropathic pain?: A cross-sectional study.
    Ünlütürk Z; Öztekin SNS; Alkan H; Şenol H; Betaş S; Erdoğan Ç
    BMC Endocr Disord; 2022 Mar; 22(1):56. PubMed ID: 35255868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persian version of the LANSS and S-LANSS questionnaires: A study for cultural adaptation and validation.
    Saghaeian SM; Salavati M; Akhbari B; Ghamkhar L; Layeghi F; Kahlaee AH
    Appl Neuropsychol Adult; 2022; 29(5):1095-1102. PubMed ID: 33232182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of neuropathic pain measurements in patients with symptoms of polyneuropathy: validation of painDETECT, Self-Completed Leeds Assessment of Neuropathic Symptoms and Signs, and Douleur Neuropathique 4.
    Dunker Ø; Grotle M; Bu Kvaløy M; Uglem M; Løseth S; Hjelland IE; Kleggetveit IP; Allen SM; Dehli Vigeland M; Munk Killingmo R; Sand T; Nilsen KB
    Pain; 2023 May; 164(5):991-1001. PubMed ID: 36240023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of neuropathic pain in treated leprosy patients in Ethiopia: a cross-sectional study.
    Haroun OMO; Hietaharju A; Bizuneh E; Tesfaye F; Brandsma WJ; Haanpää M; Rice ASC; Lockwood DNJ
    Pain; 2012 Aug; 153(8):1620-1624. PubMed ID: 22727538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain phenotype in patients with knee osteoarthritis: classification and measurement properties of painDETECT and self-report Leeds assessment of neuropathic symptoms and signs scale in a cross-sectional study.
    Moreton BJ; Tew V; das Nair R; Wheeler M; Walsh DA; Lincoln NB
    Arthritis Care Res (Hoboken); 2015 Apr; 67(4):519-28. PubMed ID: 25155472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic accuracy and test-retest reliability of the Dutch PainDETECT and the DN4 screening tools for neuropathic pain in patients with suspected cervical or lumbar radiculopathy.
    Epping R; Verhagen AP; Hoebink EA; Rooker S; Scholten-Peeters GGM
    Musculoskelet Sci Pract; 2017 Aug; 30():72-79. PubMed ID: 28600958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross-sectional study.
    Pérez C; Sánchez-Martínez N; Ballesteros A; Blanco T; Collazo A; González F; Villoria J
    Eur J Pain; 2015 Jul; 19(6):752-61. PubMed ID: 25265909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles.
    Mulvey MR; Boland EG; Bouhassira D; Freynhagen R; Hardy J; Hjermstad MJ; Mercadante S; Pérez C; Bennett MI
    Br J Anaesth; 2017 Oct; 119(4):765-774. PubMed ID: 29121284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
    Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
    Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale.
    López-de-Uralde-Villanueva I; Gil-Martínez A; Candelas-Fernández P; de Andrés-Ares J; Beltrán-Alacreu H; La Touche R
    Neurologia (Engl Ed); 2018 Oct; 33(8):505-514. PubMed ID: 27939112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.